Lentivirus-mediated gene transfer of gp91phox corrects chronic granulomatous disease (CGD) phenotype in human X-CGD cells

Journal of Gene Medicine

Volumn 2, Issue 5, 2000, Pages 317-325

  Saulnier, Sandra O ^a   Steinhoff, Dirk ^a   Dinauer, Mary C ^b   Zufferey, Romain ^c   Trono, Didier ^c   Seger, Reinhard A ^a   Hossle, Johann P ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b RILEY HOSPITAL FOR CHILDREN   (United States)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Gene therapy; Lentivirus; SIN2; X linked chronic granulomatous disease

Indexed keywords

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS;

CYBB PROTEIN, HUMAN; GREEN FLUORESCENT PROTEIN; MEMBRANE PROTEIN; PHOTOPROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; CELL DIFFERENTIATION; CELL LINE; CHRONIC GRANULOMATOUS DISEASE; CYTOLOGY; ENZYMOLOGY; GENE EXPRESSION; GENE TRANSFER; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; GRANULOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; METABOLISM; MUTATION; PHENOTYPE; REPORTER GENE; VESICULAR STOMATITIS VIRUS;

CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; GRANULOCYTES; GRANULOMATOUS DISEASE, CHRONIC; GREEN FLUORESCENT PROTEINS; HIV-1; HUMANS; LENTIVIRUS; LUMINESCENT PROTEINS; MEMBRANE GLYCOPROTEINS; MUTATION; NADPH OXIDASE; PHENOTYPE; TRANSDUCTION, GENETIC; VESICULAR STOMATITIS-INDIANA VIRUS;

EID: 0034279968     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-2254(200009/10)2:5<317::aid-jgm127>3.0.co;2-p     Document Type: Article

References (40)

1. Roos D, Curnutte JT. Chronic granulomatous disease. In Primary Immunodeficiency Diseases, Ochs HD, Smith CIE, Puck JM (eds). Oxford University Press: New York and Oxford, 1999; 353-374.
2. Ho CM, Vowels MR, Lockwood L, et al. Successful bone marrow transplantation in a child with X-linked chronic granulomatous disease. Bone Marrow Transplant 1996; 18: 213-215.
3. Calvino MC, Maldonado MS, Otheo E, et al. Bone marrow transplantation in chronic granulomatous disease. Eur J Pediatr 1996; 155: 877-879.
4. Ozsahin H, Von Planta M, Muller I, et al. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. Blood 1998; 92: 2719-2724.
5. Woodman R, Teoh D, Johnston F, et al. X-linked carriers of gp91phox chronic granulomatous disease (CGD): clinical and potential therapeutic implications of extreme unbalanced X chromosome inactivation (Abstract). Blood 1995; 86 (Suppl. 1): 27a.
6. Bjorgvinsdottir H, Ding C, Pech N, et al. Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease. Blood 1997; 89: 41-48.
7. Becker S, Wasser S, Hauses M, et al. Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells. Hum Gen Ther 1998; 9: 1561-1570.
8. Dinauer MC, Bjorgvinsdottir H, Ding C, et al. Long-term correction of phagocyte NADPH oxidase activity by retroviral-mediated gene transfer in murine X-linked chronic granulomatous disease. Blood 1999; 94: 914-922.
9. Mardiney MR, Jackson SH, Spratt SK, et al. Enhanced host defense after gene transfer in the murine p47phox-deficient model of chronic granulomatous disease. Blood 1997; 89: 2268-2275.
10. Pollock JD, Williams DA, Gifford MA, et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 1995; 9: 202-209.
11. Malech HL, Maples PB, Whiting Theobald N, et al. Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. Proc Natl Acad Sci U S A 1997; 94: 12133-12138.
12. Malech HL. Progress in gene therapy for chronic granulomatous disease. J Infect Dis 1999; 179 (Suppl. 1); 318-325.
13. Roe T, Reynolds TC, Yu G, et al. Integration of murine leukemia virus DNA depends on mitosis. EMBO J 1993; 12: 2099-2108.
14. Federico M. Lentiviruses as gene delivery vectors. Curr Opin Biotechnol 1999; 10: 448-453.
15. Trono D. Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther 2000; 7: 20-23.
16. Miyoshi H, Blömer U, Takahashi M, et al. Development of a self-inactivating lentivirus vector. J Virol 1998; 72: 8150-8157.
17. Zufferey R, Dull T, Mandel R, et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 1998; 72: 9873-9880.
18. Miyoshi H, Smith KA, Mosier DE, et al. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 1999; 283: 682-686.
19. Uchida N, Sutton RE, Friera AN, et al. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proc Natl Acad Sci U S A 1998; 95: 11939-11944.
20. Sutton RE, Wu HT, Rigg R, et al. Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells. J Virol 1998; 72: 5781-5788.
21. Case SS, Price MA, Jordan CT, et al. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. Proc Natl Acad Sci U S A 1999; 96: 2988-2993.
22. Douglas J, Kelly P, Evans JT, et al. Efficient transduction of human lymphocytes and CD34+ cells via human immunodeficiency virus-based gene transfer vectors. Hum Gene Ther 1999; 10: 935-945.
23. Ding C, Kume A, Bjorgvinsdottir H, et al. High-level reconstitution of respiratory burst activity in a human X-linked chronic granulomatous disease (X-CGD) cell line and correction of murine X-CGD bone marrow cells by retroviral-mediated gene transfer of human gp91phox. Blood 1996; 88: 1834-1840.
24. Zhen L, King AA, Xiao Y, et al. Gene targeting of X chromosome-linked chronic granulomatous disease locus in a human myeloid leukemia cell line and rescue by expression of recombinant gp91phox. Proc Natl Acad Sci U S A 1993; 90: 9832-9836.
25. Tucker KA, Lilly MB, Heck L, et al. Characterization of a new human diploid myeloid leukemia cell line (PLB-985) with granulocytic and monocytic differentiation capacity. Blood 1987; 70: 372-378.
26. Naldini L, Blomer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263-267.
27. Zufferey R, Nagy D, Mandel RJ, et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 1997; 15: 871-875.
28. Nakamura M, Murakami M, Koga T, et al. Monoclonal antibody 7D5 raised to cytochrome b558 of human neutrophils: immunocytochemical detection of the antigen in peripheral phagocytes of normal subjects, patients with chronic granulomatous disease, and their carrier mothers. Blood 1987; 69: 1404-1408.
29. Ochs HD, Igo RP. The NBT slide test: a simple screening method for detecting chronic granulomatous disease and female carriers. J Pediatr 1973; 83: 77-82.
30. Emmendorffler A, Hecht M, Lohmann-Matthes ML, et al. A fast and easy method to determine the production of reactive oxygen intermediates by human and murine phagocytes using dihydrorhodamine 123. J Immunol Methods 1990; 131: 269-275.
31. Naldini L, Blömer F, Gage FH, et al. Efficient transfer, integration and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A 1996; 93: 11382-11388.
32. DuBridge RB, Tang P, Hsia HC, et al. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 1987; 7: 379-387.
33. Dull T, Zufferey R, Kelly M, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998; 72: 8463-8471.
34. An DS, Wersto RP, Agricola BA, et al. Marking and gene expression by a lentivirus vector in transplanted human and nonhuman primate CD34+ cells. J Virol 2000; 74: 1286-1295.
35. Bukovsky A, Song J-P, Naldini L. Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells. J Virol 1999; 73: 7087-7092.
36. Kafri T, Van Praag H, Ouyang L, et al. A packaging cell line for lentivirus vectors. J Virol 1999; 73: 576-584.
37. Sutton RE, Reitsma MJ, Uchida N, et al. Transduction of human progenitor hematopoietic stem cells by human immunodeficient virus type 1-based vectors is cell cycle dependent. J Virol 1999; 73: 3649-3660.
38. Kume A, Dinauer MC. Retrovirus-mediated reconstitution of respiratory burst activity in X-linked chronic granulomatous disease cells. Blood 1994; 84: 3311-3316.
39. Li LL, Dinauer MC. Reconstitution of NADPH oxidase activity in human X-linked chronic granulomatous disease myeloid cells after stable gene transfer using a recombinant adeno-associated virus 2 vector. Blood Cells Mol Dis 1998; 24: 522-538.
40. Zentilin L, Qin G, Tafuro S, et al. Variegation of retroviral vector gene expression in myeloid cells. Gene Ther 2000; 7: 153-166.